CRIS Current Research Information System

RAVAIOLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.087
EU - Europa 2.540
AS - Asia 592
AF - Africa 200
SA - Sud America 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.074
IT - Italia 640
GB - Regno Unito 547
SE - Svezia 412
DE - Germania 336
CN - Cina 200
IN - India 166
IE - Irlanda 163
VN - Vietnam 138
BG - Bulgaria 71
RU - Federazione Russa 67
TG - Togo 56
FR - Francia 54
CI - Costa d'Avorio 53
CH - Svizzera 48
UA - Ucraina 46
ZA - Sudafrica 41
NG - Nigeria 38
EE - Estonia 34
FI - Finlandia 27
JO - Giordania 27
BE - Belgio 19
AT - Austria 15
PK - Pakistan 15
CA - Canada 12
ES - Italia 12
HR - Croazia 10
IR - Iran 10
NL - Olanda 10
GR - Grecia 9
SC - Seychelles 9
JP - Giappone 8
SG - Singapore 6
BR - Brasile 4
PE - Perù 4
BA - Bosnia-Erzegovina 3
BD - Bangladesh 3
CL - Cile 3
MK - Macedonia 3
PH - Filippine 3
PL - Polonia 3
RS - Serbia 3
AL - Albania 2
AU - Australia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HK - Hong Kong 2
ID - Indonesia 2
IQ - Iraq 2
KR - Corea 2
LB - Libano 2
RO - Romania 2
SA - Arabia Saudita 2
EC - Ecuador 1
EU - Europa 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TH - Thailandia 1
TR - Turchia 1
UG - Uganda 1
Totale 7.435
Salva come PNG Salva come JPEG
Città #
Fairfield 781
Southend 503
Chandler 415
Ashburn 352
Seattle 218
Woodbridge 217
Wilmington 182
Bologna 181
Houston 178
Cambridge 172
Dublin 163
Princeton 156
Ann Arbor 125
New York 102
Sofia 69
Dong Ket 62
Lomé 56
Abidjan 53
Redmond 46
Westminster 43
Boardman 42
Nanjing 42
Berlin 40
Bremen 39
Milan 39
Abeokuta 38
San Diego 36
Bern 35
Turin 35
Florence 33
Medford 30
Des Moines 29
Redwood City 29
Beijing 28
Amman 27
Boydton 26
Dearborn 25
Helsinki 24
Brussels 19
Rome 19
Padova 18
Saint Petersburg 18
Washington 17
Jinan 15
Falls Church 14
Nanchang 13
Shenyang 13
Los Angeles 12
Jiaxing 11
Changsha 10
Hebei 10
London 10
Bari 9
Mahé 9
Tianjin 9
Vienna 9
Forlì 7
Lübeck 7
Napoli 7
San Francisco 7
Bühl 6
Cesena 6
Frankfurt Am Main 6
Islamabad 6
Lahore 6
Leawood 6
Madrid 6
Mountain View 6
Naples 6
Norwalk 6
Ravenna 6
Reggio Emilia 6
Rimini 6
Toronto 6
Amsterdam 5
Chicago 5
Frankfurt am Main 5
Kyiv 5
San Jose 5
Singapore 5
Ardabil 4
Esslingen am Neckar 4
Fidenza 4
Fremont 4
Fukushima 4
Guangzhou 4
Imola 4
Kuban 4
Mykolayiv 4
Olalla 4
Ottawa 4
Paris 4
Pomigliano d'Arco 4
Radeberg 4
Taiyuan 4
Taizhou 4
Tehran 4
Tokyo 4
Ancona 3
Barcelona 3
Totale 5.126
Salva come PNG Salva come JPEG
Nome #
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 201
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 169
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 142
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 135
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 134
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 130
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 127
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 126
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 121
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 119
Monofocal hepatocellular carcinoma: How much does size matter? 119
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 119
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 117
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 116
null 115
Gut Microbiota and Celiac Disease 113
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 113
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 112
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 112
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 111
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 111
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 111
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 108
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 108
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 107
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 104
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 104
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 102
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 101
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 99
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 99
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 98
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 97
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 95
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 93
Pattern of macrovascular invasion in hepatocellular carcinoma 93
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 89
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 87
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection 85
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 85
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 85
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 84
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 83
null 83
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 82
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 81
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 81
Spleen stiffness by ultrasound elastography 80
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 79
Editorial: collagen proportionate area as a prognostic indicator in NAFLD 78
Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease 78
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 77
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 77
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 77
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 76
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 74
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 72
Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance 69
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 68
Non-invasive tests for the prediction of primary hepatocellular carcinoma 67
Encefalopatia epatica 67
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 64
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 64
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 63
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 63
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 61
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 60
Ruolo e significato clinico dei metodi non invasivi nella valutazione dell’ipertensione portale nel paziente affetto da epatopatia cronica 52
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 51
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 50
The role of liver and spleen elastography in advanced chronic liver disease 49
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 49
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 48
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 46
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 45
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness 45
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 43
The changing scenario of hepatocellular carcinoma in Italy: an update 42
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 41
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 40
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 38
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis 31
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 30
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 26
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 23
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 23
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 21
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 21
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 21
Reply to correspondence concerning: “Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection” 21
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 20
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 20
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 20
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 20
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 19
Correction to: Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness (Journal of Ultrasound, (2017), 20, 3, (213-225), 10.1007/s40477-017-0260-7) 19
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 19
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk 19
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 16
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 16
Totale 7.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.185
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201985 0 0 0 0 0 0 0 0 0 0 38 47
2019/20201.346 161 36 13 80 176 152 190 191 178 73 45 51
2020/20211.045 124 53 32 81 90 30 61 91 128 74 40 241
2021/20222.004 59 43 61 85 173 81 60 109 128 112 836 257
2022/20232.046 157 227 91 263 150 174 84 80 391 71 214 144
2023/2024927 62 135 72 76 92 244 33 66 53 66 28 0
Totale 7.759